Elisa Martello*, Mauro Bigliati, Donal Bisanzio, Elena Biasibetti, Franco Dosio, Daniela Pastorino, Massimo De-Nardi and Natascia Bruni
In this study, we have evaluated the efficacy of a new diet supplement in reducing chronic pain and improving mobility in a group of 10 dogs with Osteoarthritis (OA). OA is a common debilitating condition affecting humans and animals. Tablets containing a preparation of natural ingredients (Cannabidiol (CBD)-rich fraction, Boswellia serrata Roxb. in a Phytosome® delivery form and Cucumis melo L. extract) were administered for 30 days. Veterinary evaluations were performed and owners filled questionnaires on chronic pain (Helsinki chronic pain index- HCPI) three times during the study. The product was well tolerated and owners reported a good palatability and ease of administration. In terms of effectiveness, results of a Generalized Linear Mixed Model (GLMM) on HCPI highlighted a significant reduction of pain scores at the end of the study. Based on our observations, our new dietary supplement has beneficial effects in dogs with OA after the treatment.